Mcl-1 and Bcl-xLare co-regulated by IL-6 in human myeloma cells

Autor: Sophie Barillé, Phillipe Moreau, Jean-Luc Harousseau, Sophie Derenne, Régis Bataille, Denis Puthier, Martine Amiot

Publikováno v: British Journal of Haematology. 107:392-395

Multiple myeloma (MM) is a slowly proliferative malignancy in which malignant plasma cells accumulate within the bone marrow. The expression of several anti-apoptotic proteins was evaluated by immunoblotting in human myeloma cell lines and in highly

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b896a69317f43d1309575fec07faba67
https://doi.org/10.1046/j.1365-2141.1999.01705.x

American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma

Autor: Pieter Sonneveld, Sagar Lonial, Sergio Giralt, Henk M. Lokhorst, Christina Gasparreto, Raymond L. Comenzo, Jenny Bird, Bart Barlogie, Amitabha Mazumder, Shaji Kumar, Brian G.M. Durie, Hans Erik Johnsen, Edward A. Stadtmauer, Paul G. Richardson, Muzaffer Qazilbash, Saad Z. Usmani, Gösta Gahrton, Heinz Ludwig, William I. Bensinger, P. Moreau, Paremesweran Hari, Charles F. LeMaistre, David H. Vesole, H. Goldschmidt, Amrita Krishnan, Gordon Cook, Vincent Rajkumar, Antonio Palumbo, Hareth Nahi, Jin Lu, Maria V. Mateos, Michele Cavo, Joan Bladé, Javier de la Rubia, Jesús F. San Miguel, Sundar Jagannath, Christopher Bredeson, Meletios A. Dimopoulos, Ramón García-Sanz, Robert A. Kyle, Joseph R. Mikhael, P.L. McCarthy, Rafat Abonour, Yvonne A. Efebera, Eloisa Riva, M. Mohty, Robert Z. Orlowski, Douglas E. Joshua, Benedetto Bruno, Anil Nooka, Laurent Garderet, Marcelo C. Pasquini, Peter Gimsing, Ingemar Turreson, Sarah A. Holstein, Anthony Reiman, Guenther Koehne, Michel Attal, James Gajewski, Hermann Einsele, Jens Hillengass, Nicolaus Kroeger, Xavier Leleu, Kenneth C. Anderson, Orhan Sezer

Publikováno v: Biology of Blood and Marrow Transplantation, 21(12), 2039-2051. Elsevier Inc.
Giralt, S, Garderet, L, Durie, B, Cook, G, Gahrton, G, Bruno, B, Hari, P, Lokhorst, H, McCarthy, P, Krishnan, A, Sonneveld, P, Goldschmidt, H, Jagannath, S, Barlogie, B, Mateos, M, Gimsing, P, Sezer, O, Mikhael, J, Jin, L, Dimopoulos, M, Mazumder, A, Palumbo, A, Abonour, R, Anderson, K, Attal, M, Blade, J, Bird, J, Cavo, M, Comenzo, R, de la Rubia, J, Einsele, H, Garcia Sanz, R, Hillengass, J, Holstein, S, Johnsen, H E, Joshua, D, Koehne, G, Kumar, S, Kyle, R, Leleu, X, Lonial, S, Ludwig, H, Nahi, H, Nooka, A, Orlowski, R, Rajkumar, V, Reiman, A, Richardson, P, Rivas, E, San Miguel, J, Turreson, I, Usmani, S, Vesole, D, Bensinger, W, Qazilbash, M, Efebera, Y, Mohty, M, Gasparreto, C, Gajewski, J, LeMaistre, C, Bredeson, C, Moreau, P, Pasquini, M, Kroeger, N & Stadtmauer, E 2015, ' American Society of Blood and Marrow Transplant, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma ', Biology of Blood and Marrow Transplantation, vol. 21, no. 12, pp. 2039-2051 . https://doi.org/10.1016/j.bbmt.2015.09.016

In contrast to the upfront setting in which the role of high-dose therapy with autologous hematopoietic cell transplantation (HCT) as consolidation of a first remission in patients with multiple myeloma (MM) is well established, the role of high-dose

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7383a241a659f3709636c22474a6dd00
https://pubmed.ncbi.nlm.nih.gov/26428082